Orthotopic liver transplantation for treatment of patients with Budd-Chiari syndrome: A singe-center experience

Transplantation Proceedings

Volumn 32, Issue 7, 2000, Pages 2206-2207

  Rao, A R N ^a,b   Chui, A K K ^b   Gurkhan, A ^a   Shi, L W ^a   Al Harbi, I ^a   Waugh, R ^a   Verran, D J ^a   McCaughan, G W ^a   Koorey, D ^a   Shekil, A G R ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

ADULT; ARTICLE; BUDD CHIARI SYNDROME; CLINICAL ARTICLE; FEMALE; FIBRINOLYTIC THERAPY; GRAFT SURVIVAL; HUMAN TISSUE; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; ANTICOAGULANTS; FEMALE; FOLLOW-UP STUDIES; HEPATIC ENCEPHALOPATHY; HEPATIC VEIN THROMBOSIS; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SEPSIS; STREPTOCOCCAL INFECTIONS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0033674218     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(00)01636-5     Document Type: Article

References (10)

1. Tilanus HW: Br J Surg 82:1023, 1995
2. Hemming AW, Langer B, Greig P, et al: Am J Surg 171:176, 1996
3. Henderson JM, Warren WD, et al: Am J Surg 159:41, 1990
4. Ahn SS, Yellin A, Sheng FC, et al: J Vase Surg 5:28, 1987
5. Raja GS, Felver M, Ollin JW, et al: Am J Gastroenterol 91:1262, 1996
6. Kuo PC, Johnson LB, Hastings G, et al: Transplantation 62:294, 1996
7. Rogopoulos A, Gavelli A, Sokoi H, et al: Arch Surg 130:227, 1995
8. Mitchell MC, Boitnott JK, Kaufman S, et al: Medicine 61:199, 1982
9. Shaked A, Busuttil RW: Ann Surg 214:696, 1991
10. Ringe B, Lang H, Oldhafer KJ, et al: Hepatology 21:1337, 1995